Inventor

HAUPT ANDREAS

DE73 patents

⚠️ This page may combine multiple inventors who share the name “HAUPT ANDREAS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HAUPT ANDREAS

BASF AG

Dolastatin peptides

Dolastatin 15 derivatives

Dolastatin 15 derivatives

Dolastatin-15 derivatives in combination with taxanes

Dolastatin 15 derivatives

Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the C-terminus

Antitumor peptides

Peptides, the preparation and use thereof

Pentapeptides as antitumor agents

Low molecular weight inhibitors of complement proteases

Dolastatin-15 derivatives in combination with taxanes

Preparation of active peptides

Compounds useful for the synthesis of dolastatin analogs

Compounds useful for the synthesis of dolastatin analogs

Active peptide and its preparation

Peptides, their preparation and use

Oligopeptides, the preparation and use thereof

Tetrapeptides as antitumor agents

Methods and compositions for treating rheumatoid arthritis

ABBOTT GMBH & CO KG

Triazole compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Dolastatin 15 derivatives

N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

N-[(piperazinyl)hetaryl]arylsulfonamide compounds

Pyrimidin-2-one compounds and their use as dopamine D3 receptor ligands

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

Antineoplastic peptides

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Triazole compounds and the therapeutic use thereof

Antineoplastic peptides

Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor

Pyrimidine compounds and use thereof

Keto lactam compounds and use thereof

Dolastatin 15 derivatives

HAUPT ANDREAS

N-phenyl- (piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenl-(piperazine or homopiperazine) compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Benzenesulfonyl or sulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor

N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-HT6 receptor

Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

LAMBDA PHYSIK AG

Device for flushing the optical path of a UV laser beam

Apparatus for purging the beam path of a UV laser beam

TURNER SEAN COLM

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin-5-HT6 receptor

Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

ABBVIE DEUTSCHLAND

Tricyclic quinoline and quinoxaline derivatives

Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators

GENESTE HERVE

Pyridin-2-one compounds and their use as modulators of the dopamine D3 receptor

Pyrimidine compounds and use thereof

DUNKER PETER

Device and method for providing a television sequence using database and user inputs

DRESCHER KARLA

Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

AMBERG WILHELM

5-ring heteroaromatic compounds and their use as binding partners for 5-HT5 receptors

BRAJE WILFRIED

1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor